Multiple sclerosis as a biological and clinical continuum: from risk factors to the early stages of disease - Top-Institutions - MDSpire

Multiple sclerosis as a biological and clinical continuum: from risk factors to the early stages of disease

  • By

  • Ana Belén Caminero

  • María Luisa Martínez Ginés

  • Montserrat Gómez Gutiérrez

  • Inmaculada García Castañón

  • May 28, 2026

  • 0 min

Share

Top Institutions in Neurology

Brief introduction explaining scope and methodology.

  • #1

    Netherlands Brain Bank
    Netherlands Brain Bank

    Amsterdam, North Holland

    Key Differentiators

    • Neurology
    • Neuroscience

  • #2

    UK MS Tissue Bank
    UK MS Tissue Bank

    London, England

    Key Differentiators

    • Neurology
    • Neuroscience

  • #3

    European Committee for Treatment and Research in Multiple Sclerosis
    European Committee for Treatment and Research in Multiple Sclerosis

    Brussels, Brussels-Capital Region

    Key Differentiators

    • Neurology
    • Research

  • #4

    VU Medical Center
    VU Medical Center

    Amsterdam, North Holland

    Key Differentiators

    • Neurology
    • Clinical Medicine

  • #5

    Netherlands Institute for Neuroscience
    Netherlands Institute for Neuroscience

    Amsterdam, North Holland

    Key Differentiators

    • Neurology
    • Neuroscience

Original Source(s)

Multiple sclerosis as a biological and clinical continuum: from risk factors to the early stages of disease

  • by Ana Belén Caminero, María Luisa Martínez Ginés, Montserrat Gómez Gutiérrez, Inmaculada García Castañón

  • May 28, 2026

Related Content

Long-Term Outcomes of Ublituximab Treatment in Multiple Sclerosis: Findings from the ULTIMATE I and II Open-Label Extension Trials

Enrichment of Immature CD10low Neutrophils in Individuals Diagnosed with Multiple Sclerosis

The epidemiological trends of multiple sclerosis among women of child-bearing age: a global analysis from 1990 to 2021 and forecasts to 2040